Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
VRXA

Updated 10/6/2026, 9:41 AM ET.

VRXA

Veraxa Biotech AG

Buy$10,060

Hosseinion Warren

Director

6,024 shat $1.67Filed Sep 29, 4:10 PM ETFiling
VRXA

Veraxa Biotech AG - Post de-SPAC

Buy$75,000

Baumann Oliver Rolf

Director

50,000 shat $1.50Filed Aug 31, 4:10 PM ETFiling
VRXA

Veraxa Biotech AG - Post de-SPAC

Buy$7,650

Antz Christoph Rudiger

Chief Executive Officer, Director

5,000 shat $1.53Filed Aug 31, 4:10 PM ETFiling

Read from public SEC filings. Not financial advice.